The North America Breast Cancer Treatment Market is expected to grow at a strong CAGR of ~9% during the forecast period (2022-2030).The increasing incidence of breast cancer cases among the population, the aging population, technological advancements, and increasing healthcare spending in several developed nations of North America region are the major factors driving the growth of the market. This increasing incidence of breast cancer is one of the primary factors driving the growth of the breast cancer treatment market in the U.S. during the forecast period. For instance, according to the American Cancer Society, breast cancer is the most common cancer among women in the United States. It was estimated that in 2021, there were about 281,550 new cases of invasive breast cancer in women in the U.S. alone. There are several factors driving the growth of the breast cancer treatment market in the US, including, advancements in technology, rising healthcare expenditure, government initiatives and growing awareness. The US government is taking several initiatives to improve breast cancer treatment and patient outcomes. Such initiatives are increasing access to breast cancer treatment and driving market growth. For instance, the Breast and Cervical Cancer Prevention and Treatment Act of 2000 provides funding for screening and treatment for low-income women with breast cancer.

Access sample report (including graphs, charts, and figures): https://univdatos.com/report/breast-cancer-treatment-market/get-a-free-sample-form.php?product_id=40546

  • FIG. 1 North America Breast Cancer Treatment Market Revenue (2020-2030)- USD Mn

 

news9.png

Based on cancer type, the market is segmented into Hormone Receptor and HER2+. Hormone receptor segment is dominating the market while HER2+ segment is anticipated to witness the highest CAGR during the forecast period. Increasing prevalence of HER2+ breast cancer along with improved clinical results are owing to the rapid growth of the HER2+ category. For Instance, as per the data of American Cancer Society and National Cancer Institute 2021, HER2+ breast cancer accounts for 14% of the total breast cancer cases. Moreover, continuous advancements in the HER2+ breast cancer therapeutics along with its role in combinational therapy is also expected to boost the breast cancer market.

For a detailed analysis of the Global Breast Cancer Treatment Market browse through :-https://univdatos.com/report/breast-cancer-treatment-market/

Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Hospital sector is expected to dominate the market as they serve as primary healthcare facility while specialty clinics category is anticipated to witness the highest CAGR during the forecast period. The benefits of specialty clinics such as expertise and specialized care, Multidisciplinary approach, availability of supportive care services, continuity of breast cancer associated care etc. are the major reasons for the rapid growth of this segment during the forecast period. Moreover, specialty clinics can provide multiple facilities including diagnostic, treatment and management of breast cancer, which is also responsible for rapid growth of this sector in future.

Global Breast Cancer Treatment Market Segmentation

Market Insight, by Therapy

  • Targeted Therapy
  • Surgery and Radiation Therapy
  • Chemotherapy
  • Immunotherapy
  • Others

Market Insights, by Cancer Type

  • Hormone Receptor
  • HER2+

Market Insights, by End-Users

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Others

Market Insight, by Region

  • North America U.S.
  •  Canada
  •  Rest of North America
  • EuropeGermany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • APACChina
  • Japan
  • India
  • Rest of APAC
  • Rest of the World